Further studies are required to better characterize the role of ADAM17 within the liver microenvironment and inflammatory milieu as it pertains to cholangiocyte response, bile duct injury, TGFα, EGFR signaling and overall cholestasis. The gene discussed is TGFA; the disease is cholestasis.